Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

C3orf20 – Neuromyelitis Optica

C3orf20 has been investigated as a candidate risk gene for Neuromyelitis Optica in a Finnish cohort of five patients via whole exome, HLA, and regulatory region sequencing (PMID:26616883). Two unrelated individuals harboured distinct rare missense variants in C3orf20, but no variant was shared across all cases and there was no familial segregation or functional validation reported. This limited genetic evidence does not support a definitive role for C3orf20 in NMO pathogenesis. Additional large‐scale studies and experimental assays are required to clarify any contribution of C3orf20 variants to NMO risk.

References

  • Journal of neuroimmunology • 2015 • Exome and regulatory element sequencing of neuromyelitis optica patients. PMID:26616883

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

Two unrelated probands with rare missense variants; no segregation or functional data ([PMID:26616883])

Genetic Evidence

Limited

Rare missense variants identified in 2 of 5 patients; absent familial or segregation support

Functional Evidence

None

No experimental or functional studies reported